Interrupting the Damage Caused by Diabetic Retinopathy
"Researchers at the University of Michigan Kellogg Eye Center have
identified a compound that could interrupt the chain of events that
cause damage to the retina in diabetic retinopathy," according to Science Daily. "The finding is
significant because it could lead to a novel therapy that targets two
mechanisms at the root of the disease: inflammation and the weakening of
the blood barrier that protects the retina." Read more.